Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for vTv Therapeutics (VTVT) over the last 11 years, with Q3 2025 value amounting to 0.56%.

  • vTv Therapeutics' Return on Capital Employed rose 600.0% to 0.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.56%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 1.24% for FY2024, which is 9700.0% up from last year.
  • Per vTv Therapeutics' latest filing, its Return on Capital Employed stood at 0.56% for Q3 2025, which was up 600.0% from 1.07% recorded in Q2 2025.
  • vTv Therapeutics' 5-year Return on Capital Employed high stood at 0.41% for Q3 2021, and its period low was 10.84% during Q4 2023.
  • In the last 5 years, vTv Therapeutics' Return on Capital Employed had a median value of 0.95% in 2022 and averaged 1.61%.
  • Within the past 5 years, the most significant YoY rise in vTv Therapeutics' Return on Capital Employed was 366800bps (2021), while the steepest drop was -101200bps (2021).
  • Over the past 5 years, vTv Therapeutics' Return on Capital Employed (Quarter) stood at 1.09% in 2021, then rose by 22bps to 0.85% in 2022, then tumbled by -1183bps to 10.84% in 2023, then skyrocketed by 94bps to 0.68% in 2024, then rose by 17bps to 0.56% in 2025.
  • Its Return on Capital Employed was 0.56% in Q3 2025, compared to 1.07% in Q2 2025 and 0.81% in Q1 2025.